Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
12/08/2026 24:34
BRIEF-Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream Aug 12 (Reuters) - PeptiDream Inc. 4587.T:
PEPTIDREAM INC. - INITIATION OF PHASE 1 CLINICAL TRIAL BY NOVARTIS MARKS MILESTONE FOR PEPTIDREAM
Source text: ID:nTStk7e5a5
Further company coverage: 4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner